Michael G. Drage, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Toll-Like Receptor 2 | 5 | 2018 | 347 | 0.860 |
Why?
|
Gallbladder | 2 | 2019 | 308 | 0.730 |
Why?
|
Coccidia | 1 | 2019 | 2 | 0.660 |
Why?
|
Lipoproteins | 4 | 2018 | 881 | 0.650 |
Why?
|
Coccidiosis | 1 | 2019 | 10 | 0.650 |
Why?
|
Gallbladder Diseases | 1 | 2019 | 141 | 0.590 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2023 | 2422 | 0.440 |
Why?
|
Mycobacterium tuberculosis | 4 | 2018 | 1914 | 0.430 |
Why?
|
Colitis, Ulcerative | 1 | 2023 | 1922 | 0.360 |
Why?
|
Glycolipids | 1 | 2010 | 206 | 0.340 |
Why?
|
Appendiceal Neoplasms | 2 | 2021 | 155 | 0.310 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 694 | 0.290 |
Why?
|
Toll-Like Receptor 1 | 4 | 2018 | 48 | 0.290 |
Why?
|
Adenocarcinoma | 5 | 2021 | 6346 | 0.290 |
Why?
|
Esophageal Neoplasms | 1 | 2017 | 1654 | 0.270 |
Why?
|
Carcinoma, Pancreatic Ductal | 3 | 2024 | 1727 | 0.270 |
Why?
|
Adenocarcinoma, Mucinous | 2 | 2021 | 517 | 0.270 |
Why?
|
Mole Rats | 2 | 2022 | 28 | 0.250 |
Why?
|
Pseudomyxoma Peritonei | 2 | 2021 | 21 | 0.230 |
Why?
|
Nuclear Proteins | 3 | 2024 | 5796 | 0.230 |
Why?
|
Rectal Neoplasms | 2 | 2023 | 1157 | 0.230 |
Why?
|
Pancreatic Neoplasms | 4 | 2024 | 5368 | 0.220 |
Why?
|
Intestinal Mucosa | 3 | 2023 | 3032 | 0.210 |
Why?
|
Aberrant Crypt Foci | 1 | 2022 | 12 | 0.200 |
Why?
|
Bacterial Proteins | 2 | 2018 | 3847 | 0.200 |
Why?
|
Mice, Mutant Strains | 1 | 2005 | 1749 | 0.190 |
Why?
|
Gliosis | 1 | 2002 | 245 | 0.190 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2021 | 168 | 0.190 |
Why?
|
Radiosurgery | 2 | 2021 | 1342 | 0.180 |
Why?
|
Gastrins | 1 | 2020 | 74 | 0.180 |
Why?
|
Gastritis, Atrophic | 1 | 2020 | 31 | 0.180 |
Why?
|
Dendritic Cells | 2 | 2009 | 2747 | 0.180 |
Why?
|
Propranolol | 1 | 2022 | 489 | 0.180 |
Why?
|
Colon | 3 | 2019 | 1792 | 0.180 |
Why?
|
Inhibins | 1 | 2021 | 210 | 0.180 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3877 | 0.180 |
Why?
|
Pyloric Antrum | 1 | 2020 | 66 | 0.180 |
Why?
|
Angiolipoma | 1 | 2020 | 11 | 0.180 |
Why?
|
Hernia | 1 | 2020 | 68 | 0.180 |
Why?
|
Observer Variation | 3 | 2021 | 2606 | 0.180 |
Why?
|
Gastric Mucosa | 2 | 2020 | 604 | 0.180 |
Why?
|
Pathology, Clinical | 2 | 2021 | 376 | 0.180 |
Why?
|
Glutens | 1 | 2022 | 240 | 0.170 |
Why?
|
Colitis, Lymphocytic | 1 | 2019 | 23 | 0.170 |
Why?
|
Colitis, Collagenous | 1 | 2019 | 25 | 0.170 |
Why?
|
Transcription Factors | 3 | 2024 | 12128 | 0.160 |
Why?
|
Interferon Type I | 1 | 2023 | 562 | 0.160 |
Why?
|
Anal Canal | 1 | 2021 | 373 | 0.160 |
Why?
|
Myeloid Cells | 2 | 2020 | 823 | 0.160 |
Why?
|
Goblet Cells | 1 | 2022 | 298 | 0.160 |
Why?
|
Environment | 1 | 2005 | 1123 | 0.160 |
Why?
|
Fibroma | 1 | 2020 | 190 | 0.160 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2002 | 389 | 0.160 |
Why?
|
Colitis, Microscopic | 1 | 2019 | 72 | 0.150 |
Why?
|
Anus Neoplasms | 1 | 2021 | 329 | 0.150 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 4174 | 0.150 |
Why?
|
Intestinal Neoplasms | 1 | 2020 | 312 | 0.150 |
Why?
|
Behavior, Animal | 2 | 2005 | 1878 | 0.140 |
Why?
|
Lipopolysaccharides | 2 | 2018 | 2206 | 0.140 |
Why?
|
Stomach Neoplasms | 2 | 2018 | 1459 | 0.140 |
Why?
|
Interleukin-12 | 1 | 2019 | 584 | 0.140 |
Why?
|
Sigmoid Diseases | 1 | 2017 | 59 | 0.140 |
Why?
|
Barrett Esophagus | 1 | 2021 | 492 | 0.140 |
Why?
|
Colon, Sigmoid | 1 | 2017 | 124 | 0.140 |
Why?
|
Neuroglia | 1 | 2002 | 956 | 0.140 |
Why?
|
Thymus Gland | 1 | 2021 | 1243 | 0.140 |
Why?
|
Cholecystectomy | 1 | 2019 | 406 | 0.140 |
Why?
|
Peritoneal Neoplasms | 2 | 2021 | 711 | 0.130 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2018 | 218 | 0.130 |
Why?
|
Polyps | 1 | 2018 | 200 | 0.130 |
Why?
|
Adenomatous Polyps | 1 | 2017 | 108 | 0.130 |
Why?
|
Mechanoreceptors | 1 | 2017 | 188 | 0.130 |
Why?
|
Cholangiocarcinoma | 1 | 2021 | 552 | 0.130 |
Why?
|
Gynecology | 1 | 2021 | 526 | 0.130 |
Why?
|
Bile Duct Neoplasms | 1 | 2021 | 605 | 0.130 |
Why?
|
Kidney Transplantation | 1 | 2010 | 4234 | 0.130 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2015 | 60 | 0.120 |
Why?
|
Pancreatectomy | 2 | 2020 | 811 | 0.120 |
Why?
|
Gastroenterology | 1 | 2021 | 577 | 0.120 |
Why?
|
Cytodiagnosis | 2 | 2015 | 447 | 0.120 |
Why?
|
Colonic Neoplasms | 2 | 2017 | 2538 | 0.120 |
Why?
|
Colonoscopy | 1 | 2023 | 1394 | 0.120 |
Why?
|
Pancreas Transplantation | 1 | 2015 | 197 | 0.120 |
Why?
|
Seizures | 2 | 2005 | 2957 | 0.120 |
Why?
|
Pathology, Surgical | 1 | 2015 | 151 | 0.120 |
Why?
|
Celiac Disease | 1 | 2022 | 821 | 0.110 |
Why?
|
Macrophages | 1 | 2009 | 5769 | 0.110 |
Why?
|
Acylation | 2 | 2010 | 96 | 0.110 |
Why?
|
Cytological Techniques | 1 | 2015 | 218 | 0.110 |
Why?
|
Longevity | 1 | 2021 | 1065 | 0.110 |
Why?
|
Immunohistochemistry | 5 | 2020 | 11076 | 0.110 |
Why?
|
Elasticity Imaging Techniques | 1 | 2018 | 392 | 0.110 |
Why?
|
Lymph Nodes | 2 | 2016 | 3466 | 0.110 |
Why?
|
Pancreas | 2 | 2020 | 1691 | 0.110 |
Why?
|
Epilepsy, Complex Partial | 2 | 2003 | 56 | 0.100 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2020 | 954 | 0.100 |
Why?
|
Humans | 40 | 2024 | 761504 | 0.100 |
Why?
|
DNA-Binding Proteins | 2 | 2017 | 9606 | 0.100 |
Why?
|
Rectum | 1 | 2017 | 892 | 0.100 |
Why?
|
Brain Death | 1 | 2015 | 357 | 0.100 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6935 | 0.100 |
Why?
|
Prevalence | 2 | 2019 | 15732 | 0.100 |
Why?
|
Fatty Liver | 1 | 2018 | 790 | 0.100 |
Why?
|
Biopsy | 5 | 2022 | 6766 | 0.100 |
Why?
|
STAT3 Transcription Factor | 1 | 2015 | 871 | 0.090 |
Why?
|
Tuberculosis | 2 | 2018 | 2017 | 0.090 |
Why?
|
Vascular Neoplasms | 1 | 2012 | 166 | 0.090 |
Why?
|
Middle Aged | 19 | 2022 | 220895 | 0.090 |
Why?
|
Phenotype | 3 | 2022 | 16591 | 0.090 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2012 | 290 | 0.080 |
Why?
|
Thrombophilia | 1 | 2012 | 305 | 0.080 |
Why?
|
Alphapapillomavirus | 1 | 2012 | 218 | 0.080 |
Why?
|
Hippocampus | 1 | 2002 | 3766 | 0.080 |
Why?
|
Toll-Like Receptor 6 | 1 | 2009 | 29 | 0.080 |
Why?
|
Phantoms, Imaging | 1 | 2018 | 2526 | 0.080 |
Why?
|
Phosphatidylinositols | 1 | 2010 | 282 | 0.080 |
Why?
|
Female | 25 | 2022 | 392644 | 0.080 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2015 | 946 | 0.080 |
Why?
|
Mice, Inbred C57BL | 6 | 2022 | 22169 | 0.080 |
Why?
|
Colitis | 1 | 2017 | 1233 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2578 | 0.080 |
Why?
|
Adult | 15 | 2022 | 221177 | 0.070 |
Why?
|
Mycobacterium bovis | 1 | 2008 | 147 | 0.070 |
Why?
|
beta-Defensins | 1 | 2007 | 59 | 0.070 |
Why?
|
Young Adult | 9 | 2021 | 59243 | 0.070 |
Why?
|
Antigen-Presenting Cells | 2 | 2008 | 964 | 0.070 |
Why?
|
Aged, 80 and over | 8 | 2020 | 58976 | 0.070 |
Why?
|
Male | 19 | 2022 | 360804 | 0.070 |
Why?
|
Carcinoma | 2 | 2015 | 2330 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6484 | 0.070 |
Why?
|
Aged | 13 | 2024 | 169289 | 0.070 |
Why?
|
Mice | 10 | 2023 | 81525 | 0.070 |
Why?
|
Macrophages, Alveolar | 1 | 2008 | 412 | 0.060 |
Why?
|
Cell Line | 2 | 2010 | 15601 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9280 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2021 | 4320 | 0.060 |
Why?
|
Lymphocyte Activation | 2 | 2019 | 5486 | 0.060 |
Why?
|
Mice, Inbred Strains | 2 | 2005 | 1762 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2023 | 15842 | 0.060 |
Why?
|
Animals | 13 | 2023 | 168459 | 0.060 |
Why?
|
Ultrasonography | 1 | 2018 | 5972 | 0.060 |
Why?
|
Hindlimb Suspension | 1 | 2005 | 75 | 0.060 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2008 | 1435 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2023 | 4580 | 0.060 |
Why?
|
Telemetry | 1 | 2005 | 199 | 0.060 |
Why?
|
Adolescent | 7 | 2021 | 88319 | 0.060 |
Why?
|
Exploratory Behavior | 1 | 2005 | 279 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2022 | 18252 | 0.050 |
Why?
|
Antigens, Bacterial | 1 | 2009 | 1155 | 0.050 |
Why?
|
Protein Structure, Tertiary | 1 | 2010 | 3792 | 0.050 |
Why?
|
Protein Binding | 2 | 2018 | 9351 | 0.050 |
Why?
|
Aging | 1 | 2022 | 8708 | 0.050 |
Why?
|
Neurons | 1 | 2002 | 9463 | 0.050 |
Why?
|
Ejaculation | 1 | 2003 | 59 | 0.050 |
Why?
|
Mice, Neurologic Mutants | 1 | 2002 | 107 | 0.050 |
Why?
|
Mossy Fibers, Hippocampal | 1 | 2002 | 29 | 0.050 |
Why?
|
Diagnosis, Differential | 4 | 2020 | 12974 | 0.050 |
Why?
|
Psychomotor Agitation | 1 | 2005 | 305 | 0.050 |
Why?
|
Isoproterenol | 1 | 2022 | 395 | 0.050 |
Why?
|
Liver | 1 | 2018 | 7529 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2015 | 2332 | 0.050 |
Why?
|
Sexual Behavior, Animal | 1 | 2003 | 120 | 0.050 |
Why?
|
Death, Sudden | 1 | 2003 | 301 | 0.050 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2002 | 553 | 0.040 |
Why?
|
Papillomavirus Infections | 1 | 2012 | 1613 | 0.040 |
Why?
|
Maternal Behavior | 1 | 2003 | 307 | 0.040 |
Why?
|
Cell Size | 1 | 2002 | 624 | 0.040 |
Why?
|
Epilepsy, Generalized | 1 | 2003 | 178 | 0.040 |
Why?
|
Prognosis | 2 | 2020 | 29625 | 0.040 |
Why?
|
Retrospective Studies | 5 | 2021 | 80636 | 0.040 |
Why?
|
Models, Molecular | 1 | 2010 | 5439 | 0.040 |
Why?
|
Intestinal Polyps | 1 | 2020 | 104 | 0.040 |
Why?
|
Pyramidal Cells | 1 | 2002 | 369 | 0.040 |
Why?
|
Prospective Studies | 3 | 2020 | 54425 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2022 | 784 | 0.040 |
Why?
|
False Negative Reactions | 1 | 2020 | 573 | 0.040 |
Why?
|
Diet, Gluten-Free | 1 | 2022 | 283 | 0.040 |
Why?
|
Cohort Studies | 2 | 2020 | 41487 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2024 | 633 | 0.040 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2003 | 357 | 0.040 |
Why?
|
Duodenum | 1 | 2022 | 490 | 0.040 |
Why?
|
Hyperplasia | 1 | 2022 | 1152 | 0.040 |
Why?
|
DNA Helicases | 1 | 2024 | 851 | 0.040 |
Why?
|
Reaction Time | 1 | 2005 | 2082 | 0.040 |
Why?
|
Cell Count | 1 | 2002 | 1835 | 0.040 |
Why?
|
Gastric Fundus | 1 | 2018 | 37 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2010 | 4369 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2002 | 1069 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2014 | 4876 | 0.040 |
Why?
|
Microfilament Proteins | 1 | 2002 | 1134 | 0.040 |
Why?
|
Rheology | 1 | 2018 | 347 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2012 | 4026 | 0.030 |
Why?
|
Lymphatic Metastasis | 2 | 2016 | 2915 | 0.030 |
Why?
|
Microspheres | 1 | 2019 | 784 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2005 | 6228 | 0.030 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2020 | 478 | 0.030 |
Why?
|
Smad4 Protein | 1 | 2017 | 191 | 0.030 |
Why?
|
Mentors | 1 | 2021 | 661 | 0.030 |
Why?
|
Neoplasm Invasiveness | 2 | 2014 | 3595 | 0.030 |
Why?
|
Dietary Fats | 1 | 2003 | 1995 | 0.030 |
Why?
|
Motor Activity | 1 | 2005 | 2715 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2021 | 833 | 0.030 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2020 | 617 | 0.030 |
Why?
|
Astrocytes | 1 | 2002 | 1346 | 0.030 |
Why?
|
Microglia | 1 | 2002 | 1361 | 0.030 |
Why?
|
Tumor Burden | 1 | 2019 | 1893 | 0.030 |
Why?
|
Immunity | 1 | 2019 | 996 | 0.030 |
Why?
|
Up-Regulation | 1 | 2002 | 4124 | 0.030 |
Why?
|
Heart Rate | 1 | 2005 | 4195 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2022 | 2049 | 0.030 |
Why?
|
Protein Array Analysis | 1 | 2014 | 400 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2014 | 330 | 0.030 |
Why?
|
Neoadjuvant Therapy | 1 | 2023 | 2827 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 11742 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2016 | 970 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2019 | 3162 | 0.020 |
Why?
|
Mesoderm | 1 | 2014 | 674 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2015 | 1118 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 2015 | 785 | 0.020 |
Why?
|
Lymph Node Excision | 1 | 2016 | 1271 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2020 | 6814 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2850 | 0.020 |
Why?
|
Axilla | 1 | 2012 | 624 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2016 | 11121 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 21012 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 3123 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1612 | 0.020 |
Why?
|
Epithelium | 1 | 2014 | 1603 | 0.020 |
Why?
|
Carboplatin | 1 | 2012 | 794 | 0.020 |
Why?
|
Stem Cells | 1 | 2022 | 3522 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2014 | 736 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2244 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2012 | 1834 | 0.020 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 1 | 2007 | 76 | 0.020 |
Why?
|
Fluorouracil | 1 | 2012 | 1641 | 0.020 |
Why?
|
Tissue and Organ Procurement | 1 | 2015 | 961 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4111 | 0.020 |
Why?
|
Laryngoscopy | 1 | 2012 | 706 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10090 | 0.020 |
Why?
|
Child | 3 | 2021 | 80153 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2014 | 6132 | 0.020 |
Why?
|
Cisplatin | 1 | 2012 | 1651 | 0.020 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2012 | 801 | 0.020 |
Why?
|
Disease Susceptibility | 2 | 2003 | 1787 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2005 | 17904 | 0.020 |
Why?
|
Mutation | 1 | 2010 | 30052 | 0.020 |
Why?
|
Rats | 1 | 2021 | 23742 | 0.020 |
Why?
|
Paclitaxel | 1 | 2012 | 1732 | 0.020 |
Why?
|
Graft Survival | 1 | 2015 | 3819 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2014 | 2416 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4853 | 0.010 |
Why?
|
Immunologic Memory | 1 | 2010 | 1359 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2012 | 2010 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 2012 | 1927 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2010 | 18965 | 0.010 |
Why?
|
Nesting Behavior | 1 | 2003 | 17 | 0.010 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2007 | 587 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2023 | 64680 | 0.010 |
Why?
|
Models, Biological | 1 | 2019 | 9469 | 0.010 |
Why?
|
Blood Urea Nitrogen | 1 | 2003 | 186 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16981 | 0.010 |
Why?
|
Urethral Obstruction | 1 | 2003 | 55 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2012 | 2651 | 0.010 |
Why?
|
Graft Rejection | 1 | 2015 | 4445 | 0.010 |
Why?
|
Minisatellite Repeats | 1 | 2003 | 163 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12059 | 0.010 |
Why?
|
Urinary Retention | 1 | 2003 | 106 | 0.010 |
Why?
|
Electrolytes | 1 | 2003 | 274 | 0.010 |
Why?
|
Penis | 1 | 2003 | 212 | 0.010 |
Why?
|
Uremia | 1 | 2003 | 201 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 2003 | 749 | 0.010 |
Why?
|
Hypertension, Pulmonary | 1 | 2012 | 1578 | 0.010 |
Why?
|
Survival Rate | 1 | 2015 | 12725 | 0.010 |
Why?
|
Signal Transduction | 2 | 2018 | 23445 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13255 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2008 | 2416 | 0.010 |
Why?
|
Urethra | 1 | 2003 | 405 | 0.010 |
Why?
|
Genes, Recessive | 1 | 2003 | 623 | 0.010 |
Why?
|
Registries | 1 | 2015 | 8224 | 0.010 |
Why?
|
Monocytes | 1 | 2007 | 2570 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2003 | 2678 | 0.010 |
Why?
|
Antigens, CD | 1 | 2007 | 4003 | 0.010 |
Why?
|
Phosphorylation | 1 | 2007 | 8320 | 0.010 |
Why?
|
Genetic Markers | 1 | 2003 | 2601 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 2003 | 1768 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6485 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 10209 | 0.010 |
Why?
|
Risk Assessment | 1 | 2015 | 23995 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39106 | 0.010 |
Why?
|
Child, Preschool | 1 | 2015 | 42230 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 11903 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2008 | 11528 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20570 | 0.010 |
Why?
|
Heart Failure | 1 | 2012 | 11669 | 0.000 |
Why?
|
Kidney | 1 | 2003 | 7048 | 0.000 |
Why?
|
Time Factors | 1 | 2003 | 39967 | 0.000 |
Why?
|